Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia

Clinical trial NCT00328276 · COMPLETED

Trial details

NCT number: NCT00328276
Sponsor: China Medical University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenias Psychoses Psychotic Disorders Schizophrenic Disorders

Start date: 2004-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.